Example: stock market

Search results with tag "Gemcitabine"

Intravesical Administration of Therapeutic Medication for ...

Intravesical Administration of Therapeutic Medication for ...

www.suna.org

C. Gemcitabine: 1. Follow institutional policies for preparation of hazardous medications when preparing Gemcitabine. 2. Use Gemcitabine powder for injection 1 g or 2 g vials. 3. Reconstitute Gemcitabine 1000 mg/ 50 mL normal saline or 2000 mg/ 50-100 mL normal saline, or use premixed gemcitabine with closed system administration set.

  Gemcitabine

DRUG NAME Gemcitabine - BC Cancer

DRUG NAME Gemcitabine - BC Cancer

www.bccancer.bc.ca

Gemcitabine, a pyrimidine analog, is structurally similar to cytarabine, but has a wider spectrum of antitumour activity due to its different cellular pharmacology and mechanism of action.1 Gemcitabine is metabolized intracellularly to two active metabolites, gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). The cytotoxic

  Gemcitabine

For the Patient Gemcitabine Other names: GEMZAR®

For the Patient Gemcitabine Other names: GEMZAR®

www.bccancer.bc.ca

Gemcitabine For the Patient: Gemcitabine Other names: GEMZAR® • Gemcitabine (jem-SITE-a-been) is a drug that is used to treat some kinds of cancer. It is a clear liquid that is injected into a vein. • A blood test may be taken before each treatment. The dose and timing of your chemotherapy may be changed based on the test results and/or other side effects.

  Gemcitabine

Gem-Cisp: Gemcitabine/Cisplatin in Relapsed Ovarian ...

Gem-Cisp: Gemcitabine/Cisplatin in Relapsed Ovarian ...

www.londoncanceralliance.nhs.uk

Reason for Update: Network Protocol Development Gemcitabine. should be used with caution in patients with impaired renal function: CrCl (ml/min) Gemcitabine Dose

  Cisplatin, Gemcitabine

PATIENT INFORMATION Gemcitabine for Bladder Cancer

PATIENT INFORMATION Gemcitabine for Bladder Cancer

www.wsh.nhs.uk

Gemcitabine for Bladder Cancer This information sheet has been given to you to explain the use of gemcitabine to treat your non-muscle invasive bladder cancer. Sometimes this type of cancer is known as superficial bladder cancer. We are offering you this treatment as the standard treatment is currently unavailable.

  Gemcitabine

R-GDP: Rituximab, Gemcitabine, Dexamethasone &Cisplatin

R-GDP: Rituximab, Gemcitabine, Dexamethasone &Cisplatin

nssg.oxford-haematology.org.uk

Gemcitabine: limited information, consider dose reduction if bilirubin elevated. If bilirubin >27 micromol/L, then initiate treatment at 800 mg/m 2. R educe gemcitabine and cisplatin doses to 75 % and 50% doses for all other grade 3 or 4 non - haematological toxicities respectively.

  Gemcitabine

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

www.ema.europa.eu

combination with gemcitabine, 41% were 65 years and older and 10% were 75 years and older. In patients aged 75 years and older who received Abraxane and gemcitabine, there was a higher incidence of serious adverse reactions and adverse reactions that led to treatment discontinuation (see section 4.4). Patients

  Gemcitabine

Protocol: Carboplatin/Gemcitabine - Mid-Western Cancer …

Protocol: Carboplatin/Gemcitabine - Mid-Western Cancer …

www.midwesterncancercentre.ie

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 2 Protocol: Cisplatin/Gemcitabine Indications: Lung Cancer (non-small cell) – Adjuvant, Neoadjuvant

  Protocol, Carboplatin, Gemcitabine, Carboplatin gemcitabine

Sr. Drug Generic Name of the Medicine Unit Size MRP ...

Sr. Drug Generic Name of the Medicine Unit Size MRP ...

janaushadhi.gov.in

73 156 Doxorubicin Injection IP 50mg Vial Vial 250.5 0 Anticancer/Oncology 74 158 Etoposide 100 mg/5ml Inj. Vial Vial & wfi 76.06 Anticancer/Oncology 75 159 Gemcitabine 1000 mg Inj. Vial Vial 760.0 0 Anticancer/Oncology 76 160 Gemcitabine Injection IP 200mg Vial Vial 182.0 0 Anticancer/Oncology

  Injection, Gemcitabine, Gemcitabine injection

GEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for ...

GEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for ...

www.londoncanceralliance.nhs.uk

GEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for relapsed / refractory Lymphoma Page 1 of 4 Reason for Update: Network Protocol Development Approved by Consultant: P Fields 29/03/2012 Version: 1 Approved by Chair Haem TWG: Majid Kazmi

  Rituximab, Refractory, Gemcitabine, Oxaliplatin, Relapsed, Gemox r, Gemox, Oxaliplatin rituximab, For relapsed refractory

ANAL CANCER - Jones & Bartlett Learning

ANAL CANCER - Jones & Bartlett Learning

samples.jbpub.com

Biliary Tract Cancer 7 Gemcitabine Cisplatin Baseline laboratory tests: CBC: Chemistry panel, LFTs, creatinine clearance, and CA 19-9 Baseline procedures or tests: N/A Initiate IV: 0.9% sodium chloride Premedicate: 5-HT 3 and dexamethasone 10–20 mg in 100 cc of NS Administer: Gemcitabine _____ mg (1250 mg/m2) IV on days 1 and 8 • Available in 1-g or 200-mg vials; reconstitute with 0.9% ...

  Cisplatin, Gemcitabine, Gemcitabine cisplatin

Medi-Cal Rx Contract Drugs List - Therapeutic Classifications

Medi-Cal Rx Contract Drugs List - Therapeutic Classifications

medi-calrx.dhcs.ca.gov

Gemcitabine HCl Thioguanine (Gemtuzumab Ozogamicin) Thiotepa Gilteritinib Tisotumab Vedotin-TFTV Glasdegib Tivozanib Hydroxyurea Topotecan HCl ... Iron Dextran Injection . DHCS – (CDL) Therapeutic Classifications 20 02/01/2022 Blood Modifiers Hematopoietic Epoetin Alfa Thrombocytopenic Anagrelide Hydrochloride

  Injection, Gemcitabine, Gemcitabine hcl

BCCA Protocol Summary for Adjuvant Chemotherapy for ...

BCCA Protocol Summary for Adjuvant Chemotherapy for ...

www.bccancer.bc.ca

BCCA Protocol Summary for Adjuvant Chemotherapy for Resected Pancreatic AdenocarcinomaUsing Capecitabine and Gemcitabine . Protocol Code GIPAJGCAP Tumour Group Gastrointestinal Contact Physician GI Systemic Therapy . ELIGIBILITY:

  Pancreatic, Chemotherapy, Secreted, Capecitabine, Gemcitabine, Adenocarcinomausing, Chemotherapy for resected pancreatic adenocarcinomausing capecitabine and gemcitabine

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

www.ema.europa.eu

3 Bevacizumab, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum -sensitive

  Carboplatin, Gemcitabine, Bevacizumab

Chemotherapy Sequencing Guide – For therapies given on …

Chemotherapy Sequencing Guide – For therapies given on …

sites.mckesson.com

Bevacizumab Bleomycin Carboplatin Cisplatin Cyclophosphamide Cytarabine Dacarbazine Docetaxel Doxorubicin Epirubicin Etoposide Fludarabine Fluorouracil Gemcitabine ...

  Guide, Sequencing, Therapies, Chemotherapy, Carboplatin, Gemcitabine, Chemotherapy sequencing guide for therapies, Bevacizumab

Page 1 of 4 Paclitaxel Albumin (Abraxane®) and …

Page 1 of 4 Paclitaxel Albumin (Abraxane®) and …

www.londoncanceralliance.nhs.uk

Haemolytic uraemic Gemcitabine should be discontinued at the first signs of any evidence of . syndrome microangiopathic haemolytic anaemia, such as rapidly falling haemoglobin with

  Gemcitabine, Paclitaxel, Albumin, 1 of 4 paclitaxel albumin

Thésaurus régional harmonisé des protocoles de …

Thésaurus régional harmonisé des protocoles de …

www.omedit-hautenormandie.fr

Document créé le : 16/12/2014 Document validé le : 19/11/2015 - 7 - Sommaire Bevacizumab - Gemcitabine – Carboplatine Périodicité Molécules Posologie

  Gemcitabine

HIGHLIGHTS OF PRESCRIBING INFORMATION ...

HIGHLIGHTS OF PRESCRIBING INFORMATION ...

pi.lilly.com

GEMZAR (gemcitabine)for injection, for intravenous use Initial U.S. Approval: 1996-----RECENT MAJOR CHANGES-----Warnings and Precautions, Hemolytic Uremic Syndrome (5.4) 5/2019-----INDICATIONS AND USAGE----- GEMZAR® is a nucleoside metabolic inhibitor indicated: • incombination with carboplatin, for the treatment of advanced ...

  Gemcitabine, Gemzar

Extended-infusion piperacillin/tazobactam (Zosyn ...

Extended-infusion piperacillin/tazobactam (Zosyn ...

asp.mednet.ucla.edu

Gemcitabine Haloperidol Hydroxyzine Idarubicin Mitomycin Mitoxantrone Nalbuphine Prochlorperazine Promethazine Streptozocin Tobramycinb Cisatracuriumc Vancomycind aTable lists known Y-site incompatibilities with pip/tazo, for all other agents, refer to Micromedex for compatibility information

  Gemcitabine

Protocol: ABVD - Mid-Western Cancer Centre

Protocol: ABVD - Mid-Western Cancer Centre

www.midwesterncancercentre.ie

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 86 Protocol: GDP (Gemcitabine/Dexamethasone/Cisplatin) Indications: Recurrent lymphoma and Hodgkin ...

  Cisplatin, Abvd, Gemcitabine

Gemcitabine 200mg and 1 mg Powder for Solution for ...

Gemcitabine 200mg and 1 mg Powder for Solution for ...

www.mhra.gov.uk

MHRA PAR; GEMCITABINE 200 MG AND 1 G POWDER FOR SOLUTION FOR INFUSION, PL 20176/0048-9 6 The manufacturing process is referenced to a drug master file (DMF).

  Solutions, Drug, Powder, Infusion, Gemcitabine, Powder for solution for infusion

Gemcitabine – Capecitabine for Palliative Pancreatic Cancer

GemcitabineCapecitabine for Palliative Pancreatic Cancer

www.londoncanceralliance.nhs.uk

Reason for Update:Protocol Development Version: 1 Approved by Consultant: Paul Ross Supersedes: All other versions Date: 05/02/2016 Prepared by: Melanie Dalby 02/02/2016 Checked by …

  Capecitabine, Gemcitabine

Similar queries